March 20, 2018 / 1:00 PM / 9 months ago

BRIEF-Zealand Pharma: Positive Results From First Phase 3 Trial For Treatment Of Severe Hypoglycemia

March 20 (Reuters) - ZEALAND PHARMA A/S:

* REG-ZEALAND PHARMA’S FIRST PHASE 3 TRIAL WITH DASIGLUCAGON FOR TREATMENT OF SEVERE HYPOGLYCEMIA SUCCESSFULLY MEETS ITS PRIMARY OBJECTIVE

* ‍RESULTS CONFIRM DASIGLUCAGON’S SAFETY PROFILE WITH NO TREATMENT-INDUCED OR TREATMENT-BOOSTED ANTI-DRUG ANTIBODIES​

* ‍ADDITIONAL RESULTS FROM THIS PHASE 3 TRIAL WILL BE AVAILABLE IN Q2 2018​

* ‍ADDITIONAL RESULTS FROM TRIAL ARE EXPECTED IN Q2 2018​

* ‍RESULTS FROM PIVOTAL PHASE 3 EFFICACY TRIAL ARE EXPECTED IN H2 2018.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below